Trial Details
COMPLETEDBasic Information
| Clinical ID | c1260 |
|---|---|
| Identifier | NCT01550965 |
| Trial Title | A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: Adalimumab |
Participant Information
| Sponsor | AbbVie (prior sponsor, Abbott) |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-05-12 |
|---|---|
| Primary Completion Date | 2025-04-15 |
| Completion Date | 2025-04-15 |